:: صفحه اصلي :: درباره نشريه :: جستجو :: ثبت نام :: ارسال مقاله :: تماس با ما ::
:: دوره 6، شماره 1 - ( 4-1398 ) ::
جلد 6 شماره 1 صفحات 29-32 برگشت به فهرست نسخه ها
The Current Status of Bacillus Calmette‐Guérin Vaccine Protective Efficacy
چکیده:   (2443 مشاهده)
The bacillus Calmette‐Guérin (BCG) vaccine against pulmonary tuberculosis (TB) remains with poor protective efficacy. However BCG is the only licensed vaccine against human TB. This review discusses the main research progress in the field of TB vaccine development and will summarize the current status, and main challenges for the development of a safer and more efficient TB vaccine.
متن کامل [PDF 374 kb]   (245 دریافت)    
نوع مطالعه: Review article | موضوع مقاله: Vaccine development, efficacy and safety evaluation
دریافت: 1398/10/26 | پذیرش: 1398/12/21 | انتشار: 1399/1/25
ارسال نظر درباره این مقاله
نام کاربری یا پست الکترونیک شما:

CAPTCHA



XML   English Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Méndez-Samperio P. The Current Status of Bacillus Calmette‐Guérin Vaccine Protective Efficacy. vacres. 2019; 6 (1) :29-32
URL: http://vacres.pasteur.ac.ir/article-1-166-fa.html

The Current Status of Bacillus Calmette‐Guérin Vaccine Protective Efficacy. Vaccine Research. 1398; 6 (1) :29-32

URL: http://vacres.pasteur.ac.ir/article-1-166-fa.html



دوره 6، شماره 1 - ( 4-1398 ) برگشت به فهرست نسخه ها
تحقیقات واکسن Vaccine Research
Persian site map - English site map - Created in 0.18 seconds with 33 queries by YEKTAWEB 4210
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.